| Diego Jose Heredia Vintimilla, MD | |
|
500 Arcade Ave Ste 210, Elkhart, IN 46514-2485 | |
| (574) 389-5656 | |
| (574) 523-7891 |
| Full Name | Diego Jose Heredia Vintimilla |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 18 Years |
| Location | 500 Arcade Ave Ste 210, Elkhart, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831321942 | NPI | - | NPPES |
| 201289950 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elkhart General Hospital | Elkhart, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non-small-cell lung cancer (NSCLC). Little is known about cancers harboring these mutations aside from their lack of response to EGFR tyrosine kinase inhibitors, impairing the development of effective targeted therapies. A recent study published in the February 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concludes that patients with EGFR exon 20 insertions have similar clinical characteristics to those with common EGFR mutations, but a poorer prognosis.
In the latest observational study sponsored by the American Society for Microbiology and the American Cleaning Institute- (formerly The Soap and Detergent Association), 85% of adults washed their hands in public restrooms, compared with 77% in 2007. The 85% total was actually the highest observed since these studies began in 1996. The results were announced at the Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting sponsored by the American Society for Microbiology.
Children adopted from overseas have disability rates similar to those adopted from within the United States, according to new research from the University of North Carolina at Chapel Hill.
UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML).
› Verified 5 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non-small-cell lung cancer (NSCLC). Little is known about cancers harboring these mutations aside from their lack of response to EGFR tyrosine kinase inhibitors, impairing the development of effective targeted therapies. A recent study published in the February 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concludes that patients with EGFR exon 20 insertions have similar clinical characteristics to those with common EGFR mutations, but a poorer prognosis.
In the latest observational study sponsored by the American Society for Microbiology and the American Cleaning Institute- (formerly The Soap and Detergent Association), 85% of adults washed their hands in public restrooms, compared with 77% in 2007. The 85% total was actually the highest observed since these studies began in 1996. The results were announced at the Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting sponsored by the American Society for Microbiology.
Children adopted from overseas have disability rates similar to those adopted from within the United States, according to new research from the University of North Carolina at Chapel Hill.
UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diego Jose Heredia Vintimilla, MD 3245 Health Dr Ste 100, Granger, IN 46530-1380 Ph: (574) 647-1840 | Diego Jose Heredia Vintimilla, MD 500 Arcade Ave Ste 210, Elkhart, IN 46514-2485 Ph: (574) 389-5656 |
News Archive
Exon 20 insertions are the third most common family of epidermal growth factor receptor (EGFR) mutations found in non-small-cell lung cancer (NSCLC). Little is known about cancers harboring these mutations aside from their lack of response to EGFR tyrosine kinase inhibitors, impairing the development of effective targeted therapies. A recent study published in the February 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concludes that patients with EGFR exon 20 insertions have similar clinical characteristics to those with common EGFR mutations, but a poorer prognosis.
In the latest observational study sponsored by the American Society for Microbiology and the American Cleaning Institute- (formerly The Soap and Detergent Association), 85% of adults washed their hands in public restrooms, compared with 77% in 2007. The 85% total was actually the highest observed since these studies began in 1996. The results were announced at the Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting sponsored by the American Society for Microbiology.
Children adopted from overseas have disability rates similar to those adopted from within the United States, according to new research from the University of North Carolina at Chapel Hill.
UK and European research collaborations in cancer research have received a vote of confidence by three major cancer charities, with an announcement today of approximately £30 million into six international projects.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML).
› Verified 5 days ago
Mr. Gordon M Hughes, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 S Nappanee St, Elkhart, IN 46514 Phone: 574-296-3200 | |
Dr. Bruce A. Lockwitz, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 303 S Nappanee St, Elkhart, IN 46514 Phone: 574-296-3307 Fax: 574-296-3928 | |
Dr. George Collins Nwadiaro, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 S Nappanee St, Elkhart, IN 46514 Phone: 574-296-3200 Fax: 574-296-3300 | |
Essam A. Montasir, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 236 Simpson Ave, Elkhart, IN 46516 Phone: 574-293-0052 Fax: 574-293-1739 | |
Muhammad A Saeed, M.D Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Arcade Ave Ste 210, Elkhart, IN 46514 Phone: 574-389-5656 Fax: 574-523-7891 | |
Adil Wani, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Arcade Ave Ste 400, Elkhart, IN 46514 Phone: 574-522-2284 Fax: 574-522-3952 | |
Dr. Luisito C. Gonzales, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 S Nappanee St, Suite A, Elkhart, IN 46514 Phone: 574-296-3338 Fax: 574-296-3332 |